Delivery Order SPE2DB20D7059-SPE2DB25FQMN2
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $1,798.12 delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/ml vials, with a completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a $3,053.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/mL in vial form. The contract, with an ultimate completion date of November 28, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,174.24 by the Defense Logistics Agency Medical Supply Chain on August 11, 2025, for the supply of Hydralazine Hydrochloride. This firm fixed-price, competitively awarded contract is scheduled for completion by September 8, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,911.53 to AmerisourceBergen Drug Corp for the supply of Hydralazine Hydrochloride, a cardiovascular medication used in federal medical procurement. The contract, awarded on October 28, 2025, with an ultimate completion date of November 25, 2025, operates under firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- <p>The Defense Logistics Agency Troop Support Medical awarded a $225,240 delivery order to Amerisourcebergen Drug Corporation for 4561404040 Hydralazine 20 MG/ML Vial ML. The contract has a firm fixed price and performance will take place in Conshohocken, Pennsylvania from July 4-5, 2023. As a major pharmaceutical supplier, Amerisourcebergen will deliver this medication to support the DLA's medical logistics programs. No set aside designation or subcontractors were indicated.</p>
- This federal contract award, valued at $1,035.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566616068 - HYDRALAZINE 20 MG/ML VIAL. The award is a Firm Fixed Price Delivery Order contract with a completion date of December 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products...
- The Defense Logistics Agency awarded a $1,130.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydromorphone 0.5 mg/0.5 mL pharmaceutical supply, with a completion date of September 16, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,133.73 to AmerisourceBergen Drug Corp for Hydromorphone 2 mg/ml vials, with performance in Conshohocken, Pennsylvania and completion scheduled for November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation, reflecting the contractor's established capability to support federal pharmaceutical procurement requirements through open competition. This award operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,705.93 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order (4568785087) is for pharmaceutical products specified as "DT 1C 2.25X4 700/RL 6RL/BX DHAPCL," to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement, consistent with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,550.16 by the Defense Logistics Agency on November 4, 2025, with completion scheduled for November 5, 2025. The delivery order, designated as AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S, pertains to pharmaceutical products and represents a firm fixed-price, competitively awarded contract with no set-aside designation. This award is issued under...